| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.6M | — | -56.7% |
| SG&A Expense | $2.5M | — | -80.0% |
| Operating Income | -$6.1M | — | +70.5% |
| Pre-tax Income | -$5.5M | — | +71.8% |
| Income Tax | -$16K | — | +27.3% |
| Net Income | -$5.5M | — | +71.8% |
| EPS (Basic) | -$0.14 | — | +71.4% |
| EPS (Diluted) | -$0.14 | — | +71.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.9M | -6.5% | -33.6% |
| Current Assets | $72.7M | -6.6% | -33.9% |
| Total Assets | $92.1M | -6.1% | -35.1% |
| Current Liabilities | $12.0M | +19.8% | +0.2% |
| Total Liabilities | $25.7M | +7.5% | -2.8% |
| Stockholders' Equity | $66.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | +77.4% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $55K | — | +1200.0% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$3.4M | — | +77.4% |
| -42.5% |